Insider trading

Period: 120 months Stock: CVS Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

21 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

21 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

21 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

21 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
21 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
21 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

21 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
21 May 2026
ROBBINS LARRY Director · indirect
Sold at will
$34.62M 370,462 at 93.45
7.1%
Not planned
20 May 2026
ROBBINS LARRY Director · indirect
Sold at will 4×
$95.51M 1,018,000 at 93.82
16.4%
Not planned
19 May 2026
ROBBINS LARRY Director · indirect
Sold at will 2×
$187.34M 1,983,538 at 94.45
24.2%
Not planned
8 May 2026
Mandadi Tilak EVP, Chief Exp & Tech Officer
Sold at will
$6.23M 69,551 at 89.58
87.3%
Sold half or more
20 Aug 2025
Finucane Anne A. Director · indirect
Sold at will
$532.65K 7,500 at 71.02
25.3%
Not planned
5 Jun 2025
SANSONE GUY P Director
Bought
$100.01K 1,570 at 63.70
15.0%
First buy on file
6 May 2025
ROBBINS LARRY Director · indirect
Sold at will
$10.00M 150,000 at 66.67
1.8%
Not planned
5 May 2025
ROBBINS LARRY Director · indirect
Sold at will 2×
$89.25M 1,323,932 at 67.41
13.7%
Not planned
2 May 2025
ROBBINS LARRY Director · indirect
Sold at will 3×
$154.44M 2,276,068 at 67.86
19.1%
Not planned
5 Mar 2025
Clark James David SVP, Cont & Chief Acct Officer
Sold at will
$498.49K 7,513 at 66.35
47.2%
Not planned
18 Feb 2025
Bought
$2.00M 30,000 at 66.70
321%
Largest buy in 3 yrs
23 Jan 2025
Nelson Steven H EVP and President, Aetna · indirect
Bought
$1.29K 24 at 53.70
opened
First buy on file
23 Oct 2024
CAPOZZI HEIDI B EVP and Chief People Officer · indirect
Bought
$1.99K 35 at 56.85
70.0%
Largest buy in 3 yrs
2 Oct 2024
CAPOZZI HEIDI B EVP and Chief People Officer · indirect
Bought
$622.40 10 at 62.24
25.0%
+25% of stake
9 Sep 2024
CAPOZZI HEIDI B EVP and Chief People Officer · indirect
Bought
$1.98K 35 at 56.47
700%
First buy on file
2 May 2024
Bought
$500.29K 9,181 at 54.49
×52
First buy on file
2 May 2024
LUDWIG EDWARD J Director
Bought
$53.88K 1,000 at 53.88
4.8%
16 Feb 2024
Shah Prem S EVP and Pres-Pharm, Consumer W
Sold at will
$2.27M 29,473 at 76.95
42.6%
Not planned
3 Nov 2023
LUDWIG EDWARD J Director
Bought
$140.93K 2,000 at 70.47
10.7%
3 Aug 2023
Clark James David SVP, Cont & Chief Acct Officer
Sold at will 2×
$1.93M 25,759 at 74.92
84.6%
Sold half or more
3 May 2023
Lynch Karen S President and CEO
Bought
$976.57K 14,000 at 69.75
3.4%
First buy on file
Showing 1–21 of 21.